Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

R7

K-Number: K130834 · 2013-10-08

ApplicantCefla S.C.
Decision Date2013-10-08
Product CodeELC
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

R7 is the device name listed in this FDA 510(k) record. The listed applicant is Cefla S.C.. It received FDA 510(k) clearance on 2013-10-08 under 510(k) number K130834. The device is classified under product code ELC. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the R7?

R7 is a medical device that received FDA 510(k) clearance on 2013-10-08. The listed applicant is Cefla S.C.. The 510(k) number is K130834.

When did R7 receive FDA 510(k) clearance?

R7 received FDA 510(k) clearance on 2013-10-08, under 510(k) number K130834.

Who is the listed applicant for R7?

The FDA 510(k) record lists Cefla S.C. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for R7?

The FDA product code for R7 is ELC.

Other records listing Cefla S.C. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 19 devices →

Related Devices (Code: ELC)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑